158 related articles for article (PubMed ID: 7848516)
1. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.
Colotta F; Dower SK; Sims JE; Mantovani A
Immunol Today; 1994 Dec; 15(12):562-6. PubMed ID: 7848516
[TBL] [Abstract][Full Text] [Related]
2. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.
Bossù P; Visconti U; Ruggiero P; Macchia G; Muda M; Bertini R; Bizzarri C; Colagrande A; Sabbatini V; Maurizi G
Am J Pathol; 1995 Dec; 147(6):1852-61. PubMed ID: 7495308
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 (IL-1) type I receptors mediate activation of rat hypothalamus-pituitary-adrenal axis and interleukin 6 production as shown by receptor type selective deletion mutants of IL-1beta.
Van Dam AM; Malinowsky D; Lenczowski MJ; Bartfai T; Tilders FJ
Cytokine; 1998 Jun; 10(6):413-7. PubMed ID: 9632526
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
Wang J; Elewaut D; Veys EM; Verbruggen G
Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901
[TBL] [Abstract][Full Text] [Related]
5. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.
Colotta F; Saccani S; Giri JG; Dower SK; Sims JE; Introna M; Mantovani A
J Immunol; 1996 Apr; 156(7):2534-41. PubMed ID: 8786316
[TBL] [Abstract][Full Text] [Related]
6. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1.
Penton Rol G; Polentarutti N; Sironi M; Saccani S; Introna M; Mantovani A
Eur Cytokine Netw; 1997 Sep; 8(3):265-9. PubMed ID: 9346359
[TBL] [Abstract][Full Text] [Related]
8. Selectivity release of the type II decoy IL-1 receptor.
Orlando S; Polentarutti N; Mantovani A
Cytokine; 2000 Jul; 12(7):1001-6. PubMed ID: 10880245
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
Yoon DY; Dinarello CA
J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
[TBL] [Abstract][Full Text] [Related]
11. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
Burger D; Chicheportiche R; Giri JG; Dayer JM
J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1.
Glaccum MB; Stocking KL; Charrier K; Smith JL; Willis CR; Maliszewski C; Livingston DJ; Peschon JJ; Morrissey PJ
J Immunol; 1997 Oct; 159(7):3364-71. PubMed ID: 9317135
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 beta primes interleukin-8-stimulated chemotaxis and elastase release in human neutrophils via its type I receptor.
Brandolini L; Sergi R; Caselli G; Boraschi D; Locati M; Sozzani S; Bertini R
Eur Cytokine Netw; 1997 Jun; 8(2):173-8. PubMed ID: 9262966
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.
Giri JG; Wells J; Dower SK; McCall CE; Guzman RN; Slack J; Bird TA; Shanebeck K; Grabstein KH; Sims JE
J Immunol; 1994 Dec; 153(12):5802-9. PubMed ID: 7989776
[TBL] [Abstract][Full Text] [Related]
16. Human aortic endothelial cells express the type I but not the type II receptor for interleukin-1 (IL-1).
Akeson AL; Mosher LB; Woods CW; Schroeder KK; Bowlin TL
J Cell Physiol; 1992 Dec; 153(3):583-8. PubMed ID: 1360015
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-1 receptor antagonist and its delivery by gene transfer.
Evans CH; Robbins PD
Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
[TBL] [Abstract][Full Text] [Related]
18. [Progress in central interleukin-1 system and its signaling pathway].
Zheng RM; Zhu SG
Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):299-305. PubMed ID: 15727205
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 beta suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I IL-1 receptor.
Rodriguez C; Lacasse C; Hoang T
J Cell Physiol; 1996 Feb; 166(2):387-96. PubMed ID: 8591999
[TBL] [Abstract][Full Text] [Related]
20. Activation of neutral sphingomyelinase by IL-1beta requires the type 1 interleukin 1 receptor.
Nalivaeva NN; Rybakina EG; Pivanovich IYu ; Kozinets IA; Shanin SN; Bartfai T
Cytokine; 2000 Mar; 12(3):229-32. PubMed ID: 10704249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
